EU Commission Moves On GMO Directive

4 December 1997

The European Commission has proposed changes to Directive 90/220/ EEC onthe deliberate release into the environment of genetically-modified organisms. The proposal is said to improve provisions for labeling, introduces systematic consultation of the European Union's scientific committees and mandatory monitoring of products after their launch onto the market.

Environment Commissioner Ritt Bjerregaard said the proposal would make the decision-making process on GMOs more efficient and transparent. She also said she hoped that with potentially large growth prospects, the biotechnology industry would regard the new rules as a clarification and a basis for building long-term confidence and trust with the public.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight